Bacterial composition
AssigneeMicrobios, Inc.
InventorsJoseph F. Flint, Matthew Ryan Garner
Life of this patent
Estimating the term…
Abstract
A bacterial composition that inhibits E. coli O157:H7 growth by as much as 93% and Salmonella growth by as much as 97%, together with commensurate inhibition rates against the Big-Six Escherichia coli strains referred to as the non-O157 STECs that include E. coli O121:H19; E. coli O45:H2; E. coli O103:H11; E. coli O145, E. coli O26:H11; and E. coli O111. The composition is constituted of various combinations of the following four unique pathogen-inhibiting bacteria: (1) Lactobacillus animalis strain MB101; (2) Lactobacillus animalis strain MB102; (3) Enterococcus faecium strain MB505; and (4) Pediococcus acidilactici strain MB902. Each of the discovered bacteria is deposited with the American Type Culture Collection (ATCC) and respectively has an individual ATCC Accession Number.
Claims8
A composition comprising a mixture having equal viable numbers of each of the following four bacteria:
- Lactobacillus animalis strain MB101 having ATCC Accession Number PTA-121710;
- Lactobacillus animalis strain MB102 having ATCC Accession Number PTA-121711;
- Enterococcus faecium strain MB505 having ATCC Accession Number PTA-121709;
- and Pediococcus acidilactici strain MB902 having ATCC Accession Number PTA-121712;
- and wherein the mixture has an E. coli 0157:H7 growth inhibition rate of at least 93.1% when mixed with an equal number of viable E. coli 0157:H7 bacteria relative to the total number of viable bacteria comprised by the four bacteria of the mixture.
Dependencies are inferred from the claim text.